Sugi Predict

Sugi Predict / Compounds / SCHEMBL808734

SCHEMBL808734

SCHEMBL808734

CCCCCOC(=O)C=[N+]=[N-]

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 3/20 0.55
▸ ATM Q13315 1/20 0.53
▸ TSHR P16473 5/20 0.50
▸ HPGD P15428 1/20 0.50
▸ NAAA Q02083 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.44
▸ RAD52 P43351 1/20 0.44
▸ EPHX1 P07099 1/20 0.44
▸ FAAH O00519 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ MAPT P10636 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ APP P05067 3/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL809067 0.98 HCAR2 (0.56) HCAR2ATMTSHRHPGDNAAA
SCHEMBL1685669 0.98 HCAR2 (0.56) HCAR2ATMTSHRHPGDNAAA
SCHEMBL809044 0.94 ATM (0.61) HCAR2ATMTSHRHPGDNAAA
SCHEMBL9419493 0.88 TSHR (0.52) HCAR2ATMTSHRHPGDNAAA
SCHEMBL27324595 0.86 ATM (0.52) HCAR2ATMTSHRHPGDNAAA
SCHEMBL294874 0.86 — —
SCHEMBL1305254 0.77 ATM (0.86) HCAR2ATMTSHRHPGDNAAA
SCHEMBL462473 0.77 ATM (0.86) HCAR2ATMTSHRHPGDNAAA
SCHEMBL555049 0.77 ATM (0.86) HCAR2ATMTSHRHPGDNAAA
SCHEMBL7780534 0.75 HCAR2 (0.85) HCAR2ATMTSHRHPGDNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092008-A1 PROCESS FOR MAKING AN EP4 ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2025-03-20 — — US disclosed
CN-118271252-A Quinazoline derivative containing short ether chain substitution of ester group and preparation method thereof 江西师范大学 2024-07-02 — — CN disclosed
EP-4384509-A1 PROCESS FOR MAKING AN EP4 ANTAGONIST ONO Pharmaceutical Co., Ltd. (JP) 2024-06-19 — — EP disclosed
WO-2023017813-A1 PROCESS FOR MAKING AN EP4 ANTAGONIST ONO PHARMACEUTICAL CO., LTD. (JP) 2023-02-16 — — WO disclosed
CN-115160143-A Alpha-chloro-gamma-nitrate compound and preparation method thereof 上海大学 2022-10-11 — — CN disclosed
US-10207984-B2 Cyclopropyl derivatives and methods of use EMORY UNIVERSITY (US) 2019-02-19 — — US disclosed
US-20160244403-A1 Cyclopropyl Derivatives and Methods of Use UNIV EMORY (US) 2016-08-25 — — US disclosed
EP-2699539-A2 CYCLOPROPYL DERIVATIVES AND METHODS OF USE Emory University (US) 2014-02-26 — — EP disclosed
CN-101506142-B Process for production of trans-2,2-dimethyl- 3-formylcyclopropane carboxylic acid ester SUMITOMO CO LTD 2013-04-17 — — CN disclosed
US-8409831-B2 Method for producing (1S,2R)-2-chloro-2-fluorocyclopropanecarboxylic acid SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-04-02 — — US disclosed
EP-1674445-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANE COMPOUND AND ASYMMETRIC COPPER COMPLEX FOR USE IN THE SAME Sumitomo Chemical Company, Limited (JP) 2006-06-28 — — EP disclosed
EP-1593674-A1 OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2005-11-09 — — EP disclosed
US-20050010049-A1 Metal catalysts and methods for making and using same DAVIES HUW M L (US) 2005-01-13 — — US disclosed
US-6762304-B2 BIS-TRANSITION METAL CATALYSTS HAVING D2 SYMMETRY RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 2004-07-13 — — US disclosed
EP-1173278-B1 METAL CATALYSTS AND METHODS FOR MAKING AND USING SAME RES FOUNDATION OFSTATE UNIVERS (US) 2004-06-30 — — EP disclosed
US-20020183535-A1 Metal catalysts and methods for making and using same DAVIES HUW M L (US) 2002-12-05 — — US disclosed
US-6410746-B1 ORGANOMETALLIC COMPOUND CONTAINING TRANSITION METAL RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE 2002-06-25 — — US disclosed
EP-1173278-A1 METAL CATALYSTS AND METHODS FOR MAKING AND USING SAME THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2002-01-23 — — EP disclosed
WO-2000064583-A1 METAL CATALYSTS AND METHODS FOR MAKING AND USING SAME THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2000-11-02 — — WO disclosed
US-4197408-A COPPER COMPLEX CATALYST, 2,5-DIMETHYL-2,4-HEXADIEN) REACTED WITH DIAZOACETATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1980-04-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160244403-A1 Cyclopropyl Derivatives and Methods of Use CNR2, FKBP8, FKBP5 HCAR2 874/4885ATM 4095/4885TSHR 3988/4885
US-20020183535-A1 Metal catalysts and methods for making and using same COMT, SLC6A3, SLC6A2 HCAR2 4440/4885ATM 2989/4885TSHR 101/4885
US-10207984-B2 Cyclopropyl derivatives and methods of use CNR2, FKBP8, FKBP5 HCAR2 874/4885ATM 4095/4885TSHR 3988/4885
US-20250092008-A1 PROCESS FOR MAKING AN EP4 ANTAGONIST PTGER4, LTB4R2, EPB41 HCAR2 61/4885ATM 4453/4885TSHR 1750/4885
US-20050010049-A1 Metal catalysts and methods for making and using same SLC6A3, COMT, DRD4 HCAR2 3948/4885ATM 2612/4885TSHR 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.